Core Viewpoint - Southwest Securities has initiated coverage on Yuexiu Transportation Infrastructure (01052), the first highway red-chip stock listed in Hong Kong, with a "Buy" rating and a target price of HKD 5.73, anticipating the company to become a leading transportation infrastructure asset management firm in China [1]. Group 1: Company Performance - The company is strengthening its toll road business through continuous asset optimization, with projected overall revenue growth of 14.9% to CNY 2.099 billion in the first half of 2025, aided by the inclusion of the Pinglin Expressway in November 2024 [2]. - The company has maintained a stable and sustainable dividend policy since 2010, distributing approximately 50% to 60% of net profit attributable to shareholders as dividends annually [2]. - As of 2025, the company expects a net profit attributable to shareholders to grow by 14.9% to CNY 361 million [3]. Group 2: Industry Context - The highway industry in China has entered a mature phase, having completed over 70% of the mileage targets set in the National Comprehensive Transportation Network Planning Outline, with overall industry revenue steadily recovering post-pandemic [4]. - The rising costs of new road construction may lead to a revenue gap, which could be addressed through policy iterations and business diversification, as new regulations are anticipated to break the original toll duration trends [4]. Group 3: Investment and Asset Management - The company has established a unique asset layout with significant regional advantages and operational efficiency, having incubated highway assets worth nearly CNY 25 billion over the past five years [5]. - The successful establishment of a REITs platform in 2021 marks the formation of a three-platform structure (incubation platform, listed company, public REITs), enabling the company to utilize diverse financing tools and channels to optimize its capital structure [5].

对于业绩预增的核心原因，西南证券在公告中明确表示，2025年公司坚守金融服务实体经济本源，深耕 金融"五篇大文章"，深化业务创新与布局，持续打造一流区域投行、特色投行与精品投行。在资本市场 活跃度回升的有利环境下，公司积极把握市场机遇，财富管理业务、证券投资业务、投资银行业务同比 大幅增长，共同推动整体经营业绩显著提升。 据悉，西南证券将于2026年4月14日正式披露2025年年度报告，届时将公布更为详细的业务经营数据与 财务信息。西南证券表示，2025年证券行业整体受益于资本市场改革深化、交投活跃度提升及一级市场 融资回暖，西南证券凭借核心业务的均衡发展与精准的区域布局，实现了高质量增长，其业务转型成效 有望在年报中进一步显现。公司提示，本次业绩预告数据未经注册会计师审计，具体经营情况以正式披 露的年度报告为准。 中证报中证网讯（王珞）1月16日，西南证券（600369）股份有限公司（证券简称：西南证券；证券代 码：600369）披露2025年度业绩预增公告显示，公司全年经营业绩实现大幅增长，核心业务板块呈现多 点开花的良好态势。 公告显示，经财务部门初步测算，西南证券2025年度预计实现归属于母公司所有者 ...

Core Viewpoint - The CXO sector is experiencing growth driven by new molecular developments, improved market sentiment, and the increasing demand for innovative drug research in the domestic market, alongside advancements in AI-enabled drug development [1] Group 1: Market Trends - In the first half of 2024, the CXO sector continued to decline due to the impact of the U.S. Biosecurity Act and adjustments in corporate earnings growth expectations [2] - By September 2024, a policy-driven bull market emerged in the domestic stock market, leading to a simultaneous rise in CXO stock prices as geopolitical risks temporarily eased [2] - In March 2025, some leading CXO companies reported better-than-expected order data, injecting valuation into the secondary market [2] Group 2: Macroeconomic Environment - The Federal Reserve's interest rate cut cycle is expected to improve the financing environment for the pharmaceutical and biotechnology sectors, benefiting outsourcing service demand from pharmaceutical companies [3] - Geopolitical uncertainties are gradually being released, with the U.S. Fiscal Year 2026 National Defense Authorization Act already enacted, and updates to the SEC 1260H list expected to further reduce risks for leading CXO companies [3] Group 3: Industry Dynamics - Domestic demand is accelerating recovery, with the number of new drug IND applications in China steadily increasing in 2025, reaching 395, 410, 526, and 509 for Q1, Q2, Q3, and Q4 respectively [4] - The total investment in China's healthcare sector in 2025 is projected to be 93.54 billion yuan, a year-on-year increase of 83.7%, with 626 investment events recorded, up 26.7% year-on-year [4] - Globally, the healthcare sector's investment in 2025 is expected to total 591.19 billion yuan, a year-on-year decrease of 20.9%, but the decline is expected to narrow over the quarters [4]

Core Viewpoint - Southwest Securities expects a significant increase in net profit for the year 2025, driven by a recovery in capital market activity and strong performance in core business segments [1] Financial Performance - The company anticipates a net profit attributable to shareholders of between 1.028 billion to 1.098 billion yuan for 2025, representing an increase of 329 million to 399 million yuan compared to 2024, which translates to a year-on-year growth of 47% to 57% [1] - The expected net profit after deducting non-recurring items is projected to be between 1.013 billion to 1.082 billion yuan, also reflecting an increase of 324 million to 393 million yuan from 2024, with the same year-on-year growth rate of 47% to 57% [1] Business Segments - The growth in performance is attributed to the active capital market, which has allowed the company to seize market opportunities effectively [1] - Key business segments such as wealth management, securities investment, and investment banking have shown substantial year-on-year growth, contributing significantly to the overall improvement in the company's operational performance [1]

智通财经1月16日讯（记者高艳云）2025年A股市场交投活跃度刷新历史纪录，资本市场改革红利持 续，证券行业迎来史诗级业绩丰收年。 截至1月15日，中信证券、西南证券率先披露2025年业绩数据，一"大"一"小"两家代表性券商均交出超 预期答卷，头部券商中信证券归母净利润高达300.51亿元，同比大增38.46%；中小券商代表西南证券归 母净利润区间达10.28亿元至10.98亿元，同比增幅高达47%至57%。两家券商净利润合计同比增速区间 达38.75%至39.06%。 | | 券商2025业绩一 | 览(2026. 1. 16) | | | | --- | --- | --- | --- | --- | | 券商 | 净利(亿元) | 同比 | 营收(亿元) | 同比 | | 中信证券 | 300. 51 | 38. 46% | 748. 30 | 38. 46% | | 西南证券 | 10. 28 10. 98 | 47% 57% | | | | 合计 | 310. 79 311. 49 | 38.75% 39.06% | | | 两家代表性券商的超高增速，共同指向一个核心结论：2025年的增长不是简单的 ...

Group 1 - The central bank has implemented a series of measures to support high-quality economic development, including a 0.25 percentage point reduction in re-lending and rediscount rates, and an increase of 500 billion yuan in re-lending for agriculture and small enterprises [3] - The U.S. White House announced a 25% import tariff on certain semiconductor products starting January 15, affecting Nvidia's H200 chip and AMD's MI325X, while excluding semiconductors for data centers and public sectors [3] - TSMC's Q4 2025 earnings exceeded expectations with a 35% year-on-year increase in net profit to approximately $16 billion, and the company raised its 2026 capital expenditure guidance to $52-56 billion, nearly 40% higher than previous estimates [3] Group 2 - The Ministry of Commerce plans to combine policies to promote consumption and improve people's livelihoods in 2026, focusing on key areas and potential growth points [4] - The National Development and Reform Commission reported that the total social financing scale in 2025 reached 35.6 trillion yuan, with a net cash injection of 1.31 trillion yuan [5] - The financial regulatory authority emphasized the need to effectively manage risks in small financial institutions and support the real estate sector through coordinated financing mechanisms [5] Group 3 - The A-share market showed divergence with high-level stocks experiencing significant declines, while the semiconductor industry and precious metals sectors performed well [7] - The Hong Kong stock market faced fluctuations, with the Hang Seng Index down 0.28%, while real estate stocks showed resilience [7] - The first gold ETF in China surpassed 100 billion yuan in circulation, becoming the largest in Asia [8] Group 4 - Major banks in the U.S. conducted over $140 billion in dividends and stock buybacks in 2025, exceeding previous records [21] - Goldman Sachs reported a 3% decline in Q4 2025 revenue to $13.5 billion, primarily due to its credit card business, while Morgan Stanley's revenue rose 10.3% to $17.89 billion [20][21] - The Ministry of Finance and the State Taxation Administration announced tax exemptions for foreign institutions investing in government bonds and local government bonds, extending until December 31, 2027 [22]

Core Viewpoint - Southwest Securities Co., Ltd. expects a significant increase in net profit for the year 2025, projecting a rise of 47% to 57% compared to the previous year, driven by strong performance in core business segments [2][4]. Group 1: Performance Forecast - The company anticipates a net profit attributable to shareholders of the parent company between 1.028 billion yuan and 1.098 billion yuan for the year 2025, an increase of 329 million yuan to 399 million yuan year-on-year [2][4]. - The expected net profit after deducting non-recurring gains and losses is projected to be between 1.013 billion yuan and 1.082 billion yuan, also reflecting a year-on-year increase of 47% to 57% [4]. Group 2: Previous Year’s Performance - In the previous year, the total profit was 836 million yuan, with a net profit attributable to shareholders of the parent company at 699 million yuan, and a net profit after deducting non-recurring gains and losses at 689 million yuan [6]. Group 3: Reasons for Performance Increase - The increase in performance is attributed to the company's commitment to financial services for the real economy, deepening business innovation and layout, and the active engagement in capital markets, leading to significant growth in wealth management, securities investment, and investment banking businesses [8].

西南证券1月15日公告，预计2025年年度实现归母净利润10.28亿元-10.98亿元，同比增加47%-57%。 ...

Group 1 - Huasheng Tiancheng's AI-related revenue currently accounts for a low proportion of overall revenue, indicating that it does not significantly impact the company's performance [2] - CICC's merger with Dongxing Securities and Xinda Securities is still undergoing audit work, which has not yet been completed [2] - Xinhua Department Store confirmed that there are no undisclosed major matters related to semiconductor asset injections, addressing market rumors [3] Group 2 - Zhong Rare Metals signed a strategic cooperation agreement with Xian Dao Group to enhance market share and industry influence in rare metals [4] - Zhongtian Rocket reported losses in its carbon/carbon thermal field materials business due to intensified competition in the photovoltaic industry [5] - Zhongyuan Nepe proposed to acquire 59% of Zhongyuan Jikean's equity for 143 million yuan, which will make it a wholly-owned subsidiary [5] Group 3 - Jiangxi Copper's subsidiary signed a cooperation agreement with First Quantum Minerals for exploration projects [6] - China Nuclear Power's Jiangsu Xuwei Nuclear Energy Heating Power Plant's first unit is set to pour its first concrete on January 16, 2026 [6] - ST Aowei's stock may be delisted if it continues to trade below par value [6] Group 4 - Triangle Tire plans to invest 3.219 billion yuan in a new high-performance tire project in Cambodia, expected to generate annual revenue of 2.585 billion yuan [7] - Baoxin Technology intends to publicly sell part of its subsidiary's assets, with a valuation of 50.2334 million yuan [7] - Nong Shang Environment's computing infrastructure project has not progressed as planned due to funding issues [8] Group 5 - Golden Dragon Fish plans to transfer stakes in two subsidiaries to Mars China for a total of 60 million USD, which is expected to impact its 2026 earnings significantly [8] - Jin Dao Technology intends to issue convertible bonds to raise up to 306 million yuan for various projects [8] - Aerospace Information expects a net loss of 700 million to 980 million yuan for 2025 due to industry changes [10] Group 6 - Tianji Co. forecasts a net profit of 70 million to 105 million yuan for 2025, recovering from a previous loss [10] - Muyuan Foods anticipates a net profit decrease of 12.2% to 17.79% for 2025 [11] - SAIC Group expects a net profit increase of 438% to 558% for 2025, driven by sales growth [12] Group 7 - Haolaike expects a significant drop in net profit for 2025, projecting a decrease of 75.16% to 83.23% [13] - Hainan Development anticipates a net loss of 440 million to 565 million yuan for 2025 [13] - Shuangliang Energy expects to report a loss for 2025 [14] Group 8 - Aijian Group also anticipates a loss for 2025 [14] - Meijin Energy forecasts a net loss of 850 million to 1.25 billion yuan for 2025 [14] - Kunlun Wanwei expects to report a loss for 2025 [14] Group 9 - Xue Rong Biological expects a net profit of 29 million to 40 million yuan for 2025, recovering from a previous loss [15] - Xin Nuo Wei anticipates a net loss of 170 million to 255 million yuan for 2025 due to increased R&D expenses [15] - Shengnuo Biological expects a net profit increase of 204.42% to 280.53% for 2025 [16] Group 10 - Longyuan Construction forecasts a net loss of 1 billion to 1.5 billion yuan for 2025 [17] - Kosen Technology expects a net loss of 245 million to 330 million yuan for 2025 [17] - Daqian Ecology anticipates a net loss of 100 million to 120 million yuan for 2025 [17] Group 11 - Lianfa Co. expects a net profit increase of 38.92% to 58.77% for 2025 [18] - Chongqing Steel anticipates a net loss of 2.5 billion to 2.8 billion yuan for 2025, but expects to reduce losses compared to the previous year [18] - Tongxing Technology forecasts a net profit increase of 74.2% to 125.44% for 2025 [19] Group 12 - Siyuan Electric expects a net profit of 3.163 billion yuan for 2025, a 54.35% increase year-on-year [19] - Luoyang Molybdenum expects a net profit increase of 47.8% to 53.71% for 2025 [20] - Nawei Technology anticipates a net profit increase of 54.51% to 75.03% for 2025 [20] Group 13 - Jingjia Micro expects a net loss of 120 million to 180 million yuan for 2025 [21] - Southwest Securities forecasts a net profit increase of 47% to 57% for 2025 [22] - Wankai New Materials expects a net profit of 156 million to 203 million yuan for 2025, recovering from a previous loss [22] Group 14 - Yilian Network anticipates a slight decrease in net profit for 2025, projecting a decline of 0% to 4% [23] - Baofeng Energy expects a net profit increase of 73.57% to 89.34% for 2025 [23] - Sanmei Co. forecasts a net profit increase of 155.66% to 176.11% for 2025 [23] Group 15 - Zhenyu Technology expects a net profit increase of 96.89% to 116.58% for 2025 [24] - Fute Technology anticipates a net profit increase of 121.98% to 164.26% for 2025 [24] - Guoli Electronics expects a net profit increase of 124.89% to 164.57% for 2025 [24] Group 16 - Shenyu Co. expects a slight decrease in net profit for 2025, projecting a decline of 0.05% to 11.37% [25] - Rongchang Biological plans to increase its share repurchase price limit to 116 yuan per share [26] - Defu Technology plans to repurchase shares for 75 million to 150 million yuan [26] Group 17 - ST Chengchang's stock will resume trading on January 16 after completing a trading fluctuation investigation [27] - Zhi Te New Materials will also resume trading on January 16 after confirming no major changes in business operations [27] - Lio Co. will suspend trading starting January 16 for stock fluctuation investigation [27]

（编辑 任世碧） 证券日报网讯 1月15日，西南证券发布2025年年度业绩预增公告称，公司预计2025年度归属于母公司所 有者的净利润10.28亿元到10.98亿元，与上年同期相比，将增加3.29亿元到3.99亿元，同比增加47%到 57%。 ...